Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring-Reference-Cited by-同舟云学术

Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring

Published:2021-09-23 Issue: Volume: Page:1-8
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Hartinger Jan Miroslav¹,Šíma Martin¹^ORCID,Hronová Karolína¹,Halouzková Barbora Agátha¹,Szonowská Barbora²,Polakovič Vladimír²,Bednářová Vladimíra³,Hladinová Zuzana³,Tesař Vladimír³,Slanař Ondřej¹

Affiliation:

1. Department of Clinical Pharmacology and Pharmacy, Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic

2. Internal Department of Strahov, General University Hospital in Prague, Prague, Czech Republic

3. Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2021.1979747

Reference28 articles.

1. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

2. Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations

3. Vancomycin pharmacokinetics in patients with various degrees of renal function